Every material Form 8-K Vicor filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Vicor reported results for the third quarter ended September 30, 2026, with product and royalty revenue of $197.1 million, up 78.5% from $110.4 million a year earlier. Net income was $63.3 million, or $1.33 per diluted share, compared with $0.63 a year earlier, and backlog reached $406 million, up 166% from a year ago. Cash and cash equivalents rose to $513.1 million at quarter end, which shows the company's earnings growth is also reflected in its balance sheet.
Product and royalty revenue was $197.1 million, up 37.5% from $143.4 million in Q2 2026 and up 78.5% from $110.4 million a year earlier.
Net income was $63.3 million, or $1.33 per diluted share, versus $0.63 per diluted share a year earlier.
Gross margin was 68.3% of revenue, compared with 57.5% a year earlier, while operating expenses rose to $62.5 million.
Backlog was $406 million at September 30, 2026, and cash and cash equivalents were $513.1 million.
Vicor reported second-quarter 2026 results on July 21, 2026. Net income rose to $49.8 million, or $1.04 per diluted share, from $41.2 million, or $0.91 per diluted share, a year earlier, and backlog reached $380 million, up 145% from $155 million a year ago. The year-ago quarter included a $45.0 million patent litigation settlement, and the filing gives no revenue or earnings guidance for future periods.
Product and royalty revenue was $143.4 million, up 26.9% from $113.0 million in the first quarter of 2026.
Net income was $49.8 million, or $1.04 per diluted share, versus $41.2 million, or $0.91 per diluted share, in Q2 2025.
Gross margin was $83.1 million, down from $92.1 million a year earlier, which included the $45.0 million settlement.
Cash and cash equivalents were $453.6 million as of June 30, 2026, up from $404.2 million as of March 31, 2026.
Vicor reported first-quarter 2026 revenue of $113.0 million, up 20.2% from a year earlier, with net income of $20.7 million, or $0.44 per diluted share, versus $2.5 million, or $0.06 per share, a year ago. Backlog rose 75% year over year to $301 million, and management cited rising demand and a second fab plan, though operating cash flow was negative $3.9 million after a $28.6 million litigation payment.
Revenue of $113.0 million, up 20.2% from $94.0 million a year ago and up 5.3% from $107.3 million in the fourth quarter of 2025.
Net income of $20.7 million, or $0.44 per diluted share, versus $46.5 million, or $1.01 per diluted share, in the fourth quarter of 2025, which included a $27.3 million tax benefit.
Cash flow used for operations was $(3.9) million, net of a $28.6 million payment of an award for past litigation.
Backlog totaled $301 million at March 31, 2026, up 75% from a year earlier and 70% from $177 million at year-end 2025.
Vicor reported fourth-quarter 2025 net income of $46.5 million, or $1.01 per diluted share, up from $10.2 million, or $0.23, a year earlier. The result included a $27.3 million tax benefit from the partial recognition of deferred tax assets. Product revenue rose 15.3% to $92.7 million, while royalty revenue fell 7.8% to $14.5 million.
Q4 product revenue was $92.7 million, up 15.3% from $80.4 million a year earlier.
Q4 royalty revenue was $14.5 million, down 7.8% year over year and down sequentially after a catch-up amount in Q3.
Full-year 2025 net income was $118.6 million, or $2.61 per diluted share, including a $24.0 million tax benefit.
Cash and cash equivalents were $402.8 million at December 31, 2025; Q4 backlog was $176.9 million.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Vicor filing is on SEC EDGAR ↗. 8-K briefs of other companies →